Biotech financing

Innovation capital in the US by year
Innovation capital
Capital raised by commercial leaders
US$b
Source: EY, Capital IQ and VentureSource.
Innovation capital is the amount of capital raised by companies with revenues of less than US$500 million.
US commercial leaders conducted only seven financing rounds
in 2015, including four large debt deals. However, those
financings accounted for US$28.8 billion in new capital, a new
record. US innovation capital (US$32.3 billion) also reached a
new record in 2015, narrowly topping 2014’s record high of
US$30.1 billion.
Beyond borders 2016 — Biotech financing
13